what is the difference between dulaglutide and semaglutide Dosing Patterns of in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort Study | Advances in Therapy Dulaglutide vs. Semaglutide for Weight

Drafting the work or revising: all authors

The peptide will distribute throughout the body and affect all tissues with IGF-1 receptors

The ADA recommends considering initial dual therapy in individuals with an A1C greater than 9.0%

Each 10 mL multi-dose vial contains 100 mcg/mL of Vitamin B12, equivalent to ten 1 mL weekly injections, making it a convenient and cost-effective option for patients requiring regular supplementation

Active smokers unwilling to stop smoking significantly reduces graft take

Retatrutide (LY3437943) is a once-weekly injection that activates three different hormone receptors at the same time: GLP-1 (Glucagon-Like Peptide-1) receptor - controls blood sugar and appetite GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor - enhances insulin release and metabolism Glucagon receptor - increases energy expenditure and fat burning Think of it like this: Semaglutide (Ozempic) = Single agonist (GLP-1 only) Tirzepatide (Mounjaro) = Dual agonist (GLP-1 + GIP) Retatrutide = Triple agonist (GLP-1 + GIP + Glucagon) Each added receptor appears to amplify the benefits